In response to highly successful events in over the past six years, Insight Innovation Center – Chicago, formally Insight Product Development, MATTER, and the iBIO Institute are co-hosting the seventh annual HealthTECH Startup Competition on November 14th, 2019. This year our team of judges will select ten leading early-stage medical device and digital health startup finalists from the Midwest to compete for $50,000 in cash and prizes.

Upon the final application deadline on October 13th, twenty startup competitors will be selected by a judging panel comprised of leaders from global corporations, academia, investors and community health organizations. During the second and final round of vetting, the judges will identify the ten finalists that will present live at the HealthTECH Startup Competition in November. On the merit of their live pitches, jurors will award cash and prizes to the top three startups. In addition to the first, second and third place prizes, we are instituting a fourth winning category — the People’s Choice Award — that will be given to the group with the most votes on Twitter.

Please remember to promote this event on your network using the hashtag #InsightHealthTECH19

The ETA Group at Chicago Booth, the Polsky Center for Entrepreneurship and Innovation and the Kellogg Innovation & Entrepreneurship Initiative are delighted to host the 6th Annual Entrepreneurship through Acquisition Conference.

The Booth-Kellogg Entrepreneurship through Acquisition (ETA) Conference is an annual event that brings together search fund entrepreneurs, investors, MBA students, faculty, and other participants in the entrepreneurship through acquisition ecosystem to meet one another and share insights into this rapidly-growing area. This year’s conference will feature two distinct tracks: (1) Traditional ETA and (2) Alternative ETA. The Traditional ETA track will highlight ETA models employed by graduating students and young alumni, including traditional, self-funded, and incubated search funds. This track is tailored to undergraduate and MBA students as well as professionals looking to learn more about the ETA model and/or considering ETA as a potential career path. The Alternative ETA track will highlight alternative paths to ETA and the CEO role, market trends, and other important topics. Some panels in this track will be tailored to more experienced executives.

The conference is co-organized by Chicago Booth and Kellogg and offers the opportunity to meet industry experts and practicing entrepreneurs from across the country, who provide their perspectives on various aspects of the ETA model. Entrepreneurship through acquisition rests at the intersection of academia and the private sector, blending the vast knowledge and insight of academia with the wisdom and experience of practicing professionals.

CONFERENCE AGENDA:

9:00 – 9:30 am Registration and Breakfast

9:30 – 9:45 am Opening Remarks

10:00 – 10:45 am Track 1: ETA Career Path

10:00 – 10:45 amTrackt 2: Mid-Career Transition to CEO

10:45 – 11:00 am Break

11:00 – 11:45 am Track 1: The Investor Perspective

11:00 – 11:45 am Track 2: Women in ETA

12:00 – 1:00 pm Networking Lunch

1:00 – 1:45 pm Track 1: Working with the Owner

1:00 – 1:45 pm Track 2: ETA Trends and Updates

1:45 – 2:00 pm Break

2:00 – 2:45 pm Track 1: Young CEO Perspective

2:00 – 2:45 pm Track 2: Creating Value

2:45 – 3:00 pm Break

3:00 – 4:00 pmClosing Keynote with Eric Roza, CEO of DataLogix

4:00 – 5:30 pm Networking Reception (on-site)

Full details and more Information:www.etaconference.com

This seminar on veterinary medicine regulations will provide attendees with an understanding of FDA’s veterinary drug approval process.

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies.

For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.

This two day interactive course will cover:

• Premarket approval process
• Various sections of a New Animal Drug Application
• Strategies for navigating the FDA approval process

Learning Objectives:

• Understand how the U.S. Food and Drug Administration regulates veterinary drug product.
• Understand how FDA’s Center for Veterinary Medicine is organized.
• Discuss the process by which veterinary drug products are reviewed and approved.
• Learn how to open an INAD File and request fee waivers.
• Obtain a working knowledge of various sections included within an NADA.
• Develop a deep understanding of what is needed to substantiate product characterization, target safety and effectiveness.
• Gain general understanding of FDA’s rules governing chemistry, manufacturing and controls (CMC).
• Understand the various components of an animal field study to support product approval.
• Discuss the difference between FDA’s various user fees and fee waivers.
• Identify the elements of an FDA compliant label.
• Develop a corporate compliance strategy covering labeling, marketing and advertising.
• Explore problem solving methods to mitigate regulatory enforcement risks.
• Explain how jurisdiction is split between various Federal agencies in a certain cases.
• Learn how animal feed, veterinary devices, OTC drug products and nutritional supplement are regulated in the U.S.

Who Should Attend:

This course is designed for people tasked with developing and maintaining an animal health company’s product portfolio and responsible for overseeing a company’s regulatory strategies. This includes individuals responsible for overseeing regulatory affairs, developing veterinary drug products, evaluating new technologies or applications, and those tasked with ensuring corporate compliance.

Among others, this includes:

• Personnel new to the Animal Health Industry
• CRO professionals
• Entrepreneurs looking to add value to their products
• Regulatory professionals
• Compliance professionals
• U.S. Agents of Foreign Corporations
• Document control specialists
• Record retention specialists
• Legal Professionals
• Financial Advisors and Institutional Investors
• Consultants, Inspectors and cGxP Experts

For more information about this conference visit https://www.researchandmarkets.com/r/ugztf7